webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Boc-D-trans-Hyp-OH

  CAS No.: 147266-92-0   Cat No.: BADC-01919   Purity: ≥ 97% 4.5  

Boc-D-trans-Hyp-OH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). It is also an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.

Boc-D-trans-Hyp-OH

Structure of 147266-92-0

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C10H17NO5
Molecular Weight
231.25

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(2R,4S)-1-(tert-butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid; N-Boc-trans-4-hydroxy-d-proline
IUPAC Name
(2R,4S)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid
Canonical SMILES
CC(C)(C)OC(=O)N1CC(CC1C(=O)O)O
InChI
InChI=1S/C10H17NO5/c1-10(2,3)16-9(15)11-5-6(12)4-7(11)8(13)14/h6-7,12H,4-5H2,1-3H3,(H,13,14)/t6-,7+/m0/s1
InChIKey
BENKAPCDIOILGV-NKWVEPMBSA-N
Density
1.312±0.06 g/cm3
Melting Point
123°C
Boiling Point
390.9±42.0°C

Boc-D-trans-Hyp-OH, a derivative of hydroxyproline utilized in peptide synthesis and drug development, boasts a multitude of applications. Here are four key applications expressed with a high degree of perplexity and burstiness:

Peptide Synthesis: Serving as a cornerstone in cyclic peptides and peptidomimetics synthesis, Boc-D-trans-Hyp-OH elevates stability and biological activity within peptide chains. This enhancement is paramount for the creation of peptide-based drugs and therapeutic agents, propelling advancements in medical treatments.

Collagen Research: Delving into the intricacies of collagen’s structure and function, Boc-D-trans-Hyp-OH stands as a pivotal player in collagen exploration. As hydroxyproline forms an integral part of collagen, its derivatives aid in crafting collagen-like peptides for in-depth structural investigations, shedding light on collagen-related ailments like osteogenesis imperfecta.

Drug Development: Spearheading the design and synthesis of proline-rich peptides for therapeutic applications, Boc-D-trans-Hyp-OH is a driving force in drug development. These peptides often exhibit enhanced pharmacokinetics and bioavailability, offering promising avenues for drug discovery. Through the integration of Boc-D-trans-Hyp-OH, researchers can forge potent and targeted drug candidates with increased efficacy.

Structural Biology: In the realm of structural biology, Boc-D-trans-Hyp-OH serves as a linchpin for unraveling the influence of hydroxyproline on protein folding and stability. By replacing natural amino acids with Boc-D-trans-Hyp-OH, scientists delve into the dynamics and interactions of proteins, illuminating the mechanisms underlying protein-related diseases. This profound grasp of protein behavior is essential for therapeutic protein development and combating complex diseases.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Boc-D-Lys(N3)-OH CHA salt | Boc-Dap-OH.DCHA | mPEG3-amine | DBCO-PEG3-TCO | XMT-1519 conjugate-1 | NH-bis(C1-Boc) | H-D-trans-Hyp-OMe HCl | Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Br | Fluorescein-DBCO | Boc-D-trans-Hyp-OH | DBCO-PEG3-oxyamine
Send Inquiry
Verification code
Inquiry Basket